TA145: Head and neck cancer - cetuximab
This is a discussion on TA145: Head and neck cancer - cetuximab within the Updates from the Technology Assessment Authorities forum, part of the Industry News and Updates category; The summary for the published technology appraisal on Head and neck cancer - cetuximab . It links to the published guidance and ...
|
|||||||
| Register | Help | Members List | Mark Forums Read |
04-01-2010, 12:51 PM
|
|||
|
|||
TA145: Head and neck cancer - cetuximab
The summary for the published technology appraisal on Head and neck cancer - cetuximab . It links to the published guidance and key documents.
More... 
|
 |
«
Previous Thread
|
Next Thread
»
| Thread Tools | |
| Display Modes | |
Linear Mode
|
|
|
||||
| Thread | Thread Starter | Forum | Replies | Last Post |
| TA172: Head and neck cancer (squamous cell carcinoma) - cetuximab | industry_news | Updates from the Technology Assessment Authorities | 0 | 04-01-2010 12:51 PM |
| TA172: Head and neck cancer (squamous cell carcinoma) - cetuximab | industry_news | Updates from the Technology Assessment Authorities | 0 | 06-23-2009 10:37 PM |
| Black Patients Have Poorer Survival in Head and Neck Cancer | industry_news | Other Clinical Pharmacy News | 0 | 10-06-2008 04:07 PM |
| Baroreflex Failure Linked to Radiation for Head and Neck Cancer | industry_news | Other Clinical Pharmacy News | 0 | 10-03-2008 02:11 PM |
| Cetuximab Improves Survival in Head and Neck Cancer | industry_news | Other Clinical Pharmacy News | 0 | 09-11-2008 11:41 AM |
© 2008 DrugManagementForum™ powered by |
 |